Amorepacific held the 'Skin Epigenetics–Sulwhasoo Symposium' by participating in the 2023 International Society for Skin Research (ISID 2023, May 10-13) held in Tokyo, Japan.
At the symposium held on the 11th (Thursday) under the theme of 'Skin Epigenetics,' Amorepacific R&I Center shared its research achievements and suggested future research directions.
Professor Kang Se-won of the Department of Dermatology at Johns Hopkins University in the United States, who attended the symposium, presented the results of △ epigenetic research flow of skin aging △ the possibility of pharmacological control of photoaging skin from the perspective of epigenetics under the theme of 'Epigenetic landscape of Skin Aging'.
Dr. Kyu-Han Kim of Amorepacific R&I Center presented four epigenetic research cases of Amorepacific under the theme of 'Advanced epigenetic regulation for skin anti-aging'.
△ A study on the anti-inflammatory efficacy mechanism of Ginsenomics (BIOGF1K) based on ceRNA network analysis △ A study on skin barrier formation and peony extract efficacy through the epigenetic mechanism of EGR3 △ A study on epigenetic clock control of Camellia Flavonoid △ This is the content of the study on the whitening and anti-aging efficacy of miR125b and melasolv.
In December of last year, Amorepacific launched a joint research program with the Johns Hopkins University School of Medicine in the U.S. and the New Beauty Research Initiative (NBRI). Through this, we are collaborating in various fields of skin science research including epigenetics.
Park Young-ho, head of the R&I Center, added meaning, “We were able to share the latest research trends with world-class scientists on the effects of epigenetics on skin aging,” adding, “Amorepacific is introducing products that apply the results of epigenetics research and at the same time We will continue to do our best to help customers around the world become healthier and more beautiful.”